Daroand IPO lists as TSE's 41st pharmaceutical ticker

The ticker Daroand, belonging to Zist Arvand Pharmed, part of the Cinnagen pharmaceutical group, began trading on the Tehran Stock Exchange on Wednesday, September 9, 2026 (18 Shahrivar 1405), becoming the market's 41st pharmaceutical sector ticker. According to Ecoiran, the offering's estimated final valuation was put at 7,393 billion tomans. The company produces chemical drugs, specialty supplements and herbal products under more than 150 manufacturing licenses.